Friday, May 29, 2026
NewsWhite
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
WORLD
Unverified

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 29, 2026·Source: CNBC·0 views

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.

Originally reported by CNBC. Read the original article

Related Articles